Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27.2M
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
4.61M
-
Shares change
-
+2.73M
-
Total reported value, excl. options
-
$47.3M
-
Value change
-
+$28.1M
-
Put/Call ratio
-
1.06
-
Number of buys
-
32
-
Number of sells
-
-3
-
Price
-
$10.27
Significant Holders of Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) as of Q3 2019
42 filings reported holding ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share as of Q3 2019.
Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.61M shares
of 27.2M outstanding shares and own 16.98% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (1.27M shares), DFPG INVESTMENTS, INC. (460K shares), TOWNSQUARE CAPITAL LLC (452K shares), FMR LLC (400K shares), Nikko Asset Management Americas, Inc. (299K shares), Sumitomo Mitsui Trust Holdings, Inc. (299K shares), DAFNA Capital Management LLC (174K shares), SABBY MANAGEMENT, LLC (125K shares), VANGUARD GROUP INC (124K shares), and ROYCE & ASSOCIATES LP (106K shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.